• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Bull Natl Res Cent . Phylogenetic and full-length genome mutation analysis of SARS-CoV-2 in Indonesia prior to COVID-19 vaccination program in 2021

tetano

Editor, Senior Moderator
Bull Natl Res Cent


. 2021;45(1):200.
doi: 10.1186/s42269-021-00657-0. Epub 2021 Nov 21.
Phylogenetic and full-length genome mutation analysis of SARS-CoV-2 in Indonesia prior to COVID-19 vaccination program in 2021


Reviany V Nidom[SUP] 1 2 [/SUP], Setyarina Indrasari[SUP] 1 2 [/SUP], Irine Normalina[SUP] 1 2 [/SUP], Astria N Nidom[SUP] 1 [/SUP], Balqis Afifah[SUP] 1 [/SUP], Lestari Dewi[SUP] 3 [/SUP], Andra K Putra[SUP] 4 [/SUP], Arif N M Ansori[SUP] 1 5 [/SUP], Muhammad K J Kusala[SUP] 1 5 [/SUP], Mohammad Y Alamudi[SUP] 1 [/SUP], Chairul A Nidom[SUP] 1 2 6 [/SUP]



Affiliations

Abstract

Background: Indonesia has started the big project of COVID-19 vaccination program since 13 January 2021 by employing the first shot of vaccine to the President of Indonesia as the outbreak and rapid transmission of COVID-19 have endangered not only Indonesian but the global health and economy. This study aimed to investigate the full-length genome mutation analysis of 166 Indonesian SARS-CoV-2 isolates as of 12 January 2021.
Results: All data of the isolates were extracted from the Global Initiative on Sharing All Influenza Data (GISAID) EpiCoV database. CoVsurver platform was employed to investigate the full-length genome mutation analysis of all isolates. This study also focused on the phylogeny analysis in unlocking the mutation of S protein in Indonesian SARS-CoV-2 isolates. WIV04 isolate that was originated from Wuhan, China was used as the virus reference according to the CoVsurver default. The result showed that a full-length genome mutation analysis of 166 Indonesian SARS-CoV-2 isolates was successfully generated. Every single mutation in S protein was described and then visualized by utilizing BioRender platform. Furthermore, it also found that D614G mutation appeared in 103 Indonesian SARS-CoV-2 isolates.
Conclusions: To sum up, this study helped to observe the spread of COVID-19 transmission. However, it also proposed that the epidemiological surveillance and genomics studies might be improved on COVID-19 pandemic in Indonesia.
Supplementary information: The online version contains supplementary material available at 10.1186/s42269-021-00657-0.

Keywords: COVID-19; Genome analysis; Indonesia; SARS-CoV-2; Spike protein.
 
Back
Top Bottom